Stocks
Zynerba Pharmaceuticals (ZYNE) ROE US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -69.3% | -41.6% | -83.8% | -53.0% | -75.3% | -127.5% | ||
| Changes by years, y/y, % | -17pp | +28pp | -42pp | +31pp | -22pp | +7.5% | |||
Zynerba Pharmaceuticals. ROE, %
Zynerba Pharmaceuticals. ROE, changes, pp
Zynerba Pharmaceuticals (ZYNE) ROE US GAAP (quarter values) |
||||||||
| 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| ROE, % | ? | -66.4% | -68.8% | -75.9% | -94.4% | -127.5% | -127.5% | |
| Changes by years, y/y, % | -25pp | -20pp | -23pp | -37pp | -61pp | |||
| Changes by quarters, q/q, % | -9pp | -2pp | -7pp | -18pp | -33pp | |||
